Recently, the pathogenetic role of BCL11A was also highlighted in solid tumors (e.g., lung, prostate, breast cancer, endometrial carcinoma, laryngeal squamous carcinoma) (Zhang et al. 2015, 2016; Jiang et al. 2013; Khaled et al. 2015; Zhou et al. 2017; Chen et al. 2018; Wang et al. 2020). This evidence concerns the gene BCL11A and breast cancer.